Copyright Reports & Markets. All rights reserved.

Global Embolotherapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Embolotherapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Embolic Agents
      • 1.4.3 Microspheres
      • 1.4.4 Embolic Coils
      • 1.4.5 Liquid Embolic Agents
      • 1.4.6 Embolic Plug Systems
      • 1.4.7 Detachable Balloons
      • 1.4.8 Support Devices
      • 1.4.9 Microcatheters
      • 1.4.10 Guidewires
    • 1.5 Market by Application
      • 1.5.1 Global Embolotherapy Market Share by Application (2019-2025)
      • 1.5.2 Hospitals and Clinics
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Other End Users
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Embolotherapy Market Size
    • 2.2 Embolotherapy Growth Trends by Regions
      • 2.2.1 Embolotherapy Market Size by Regions (2019-2025)
      • 2.2.2 Embolotherapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Embolotherapy Market Size by by Players
      • 3.1.1 Global Embolotherapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Embolotherapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Embolotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Embolotherapy Key Players Head office and Area Served
    • 3.3 Key Players Embolotherapy Product/Solution/Service
    • 3.4 Date of Enter into Embolotherapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Embolotherapy Market Size by Type (2014-2019)
    • 4.2 Global Embolotherapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Embolotherapy Market Size (2014-2019)
    • 5.2 Embolotherapy Key Players in North America
    • 5.3 North America Embolotherapy Market Size by Type
    • 5.4 North America Embolotherapy Market Size by Application

    6 Europe

    • 6.1 Europe Embolotherapy Market Size (2014-2019)
    • 6.2 Embolotherapy Key Players in Europe
    • 6.3 Europe Embolotherapy Market Size by Type
    • 6.4 Europe Embolotherapy Market Size by Application

    7 China

    • 7.1 China Embolotherapy Market Size (2014-2019)
    • 7.2 Embolotherapy Key Players in China
    • 7.3 China Embolotherapy Market Size by Type
    • 7.4 China Embolotherapy Market Size by Application

    8 Japan

    • 8.1 Japan Embolotherapy Market Size (2014-2019)
    • 8.2 Embolotherapy Key Players in Japan
    • 8.3 Japan Embolotherapy Market Size by Type
    • 8.4 Japan Embolotherapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Embolotherapy Market Size (2014-2019)
    • 9.2 Embolotherapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Embolotherapy Market Size by Type
    • 9.4 Southeast Asia Embolotherapy Market Size by Application

    10 India

    • 10.1 India Embolotherapy Market Size (2014-2019)
    • 10.2 Embolotherapy Key Players in India
    • 10.3 India Embolotherapy Market Size by Type
    • 10.4 India Embolotherapy Market Size by Application

    11 Central and South America

    • 11.1 Central and South America Embolotherapy Market Size (2014-2019)
    • 11.2 Embolotherapy Key Players in Central and South America
    • 11.3 Central and South America Embolotherapy Market Size by Type
    • 11.4 Central and South America Embolotherapy Market Size by Application

    12 International Players Profiles

    • 12.1 Boston Scientific
      • 12.1.1 Boston Scientific Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Embolotherapy Introduction
      • 12.1.4 Boston Scientific Revenue in Embolotherapy Business (2014-2019))
      • 12.1.5 Boston Scientific Recent Development
    • 12.2 Merit Medical Systems
      • 12.2.1 Merit Medical Systems Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Embolotherapy Introduction
      • 12.2.4 Merit Medical Systems Revenue in Embolotherapy Business (2014-2019)
      • 12.2.5 Merit Medical Systems Recent Development
    • 12.3 Terumo
      • 12.3.1 Terumo Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Embolotherapy Introduction
      • 12.3.4 Terumo Revenue in Embolotherapy Business (2014-2019)
      • 12.3.5 Terumo Recent Development
    • 12.4 Medtronic plc
      • 12.4.1 Medtronic plc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Embolotherapy Introduction
      • 12.4.4 Medtronic plc Revenue in Embolotherapy Business (2014-2019)
      • 12.4.5 Medtronic plc Recent Development
    • 12.5 Johnson & Johnson
      • 12.5.1 Johnson & Johnson Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Embolotherapy Introduction
      • 12.5.4 Johnson & Johnson Revenue in Embolotherapy Business (2014-2019)
      • 12.5.5 Johnson & Johnson Recent Development
    • 12.6 Stryker
      • 12.6.1 Stryker Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Embolotherapy Introduction
      • 12.6.4 Stryker Revenue in Embolotherapy Business (2014-2019)
      • 12.6.5 Stryker Recent Development
    • 12.7 BTG plc
      • 12.7.1 BTG plc Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Embolotherapy Introduction
      • 12.7.4 BTG plc Revenue in Embolotherapy Business (2014-2019)
      • 12.7.5 BTG plc Recent Development
    • 12.8 Penumbra
      • 12.8.1 Penumbra Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Embolotherapy Introduction
      • 12.8.4 Penumbra Revenue in Embolotherapy Business (2014-2019)
      • 12.8.5 Penumbra Recent Development
    • 12.9 Cook Medical
      • 12.9.1 Cook Medical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Embolotherapy Introduction
      • 12.9.4 Cook Medical Revenue in Embolotherapy Business (2014-2019)
      • 12.9.5 Cook Medical Recent Development
    • 12.10 Abbott Laboratories
      • 12.10.1 Abbott Laboratories Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Embolotherapy Introduction
      • 12.10.4 Abbott Laboratories Revenue in Embolotherapy Business (2014-2019)
      • 12.10.5 Abbott Laboratories Recent Development
    • 12.11 Acandis GmbH
    • 12.12 BALT Extrusion
    • 12.13 Sirtex Medical Limited
    • 12.14 Kaneka
    • 12.15 Meril Life Sciences

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central and South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Embolotherapy is a minimally invasive endovascular x-ray procedure. It consists in therapeutic introduction of various substances into the circulation to occlude vessels. Embolization, or embolotherapy, is performed by radiologists.

      Embolization can be used as an independent method of treatment, and as a preoperative preparation. In this case, it is achieved to minimize blood loss and reduce the number of complications.
      In 2018, the global Embolotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Embolotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Embolotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.

      The key players covered in this study
      Boston Scientific
      Merit Medical Systems
      Terumo
      Medtronic plc
      Johnson & Johnson
      Stryker
      BTG plc
      Penumbra
      Cook Medical
      Abbott Laboratories
      Acandis GmbH
      BALT Extrusion
      Sirtex Medical Limited
      Kaneka
      Meril Life Sciences

      Market segment by Type, the product can be split into
      Embolic Agents
      Microspheres
      Embolic Coils
      Liquid Embolic Agents
      Embolic Plug Systems
      Detachable Balloons
      Support Devices
      Microcatheters
      Guidewires

      Market segment by Application, split into
      Hospitals and Clinics
      Ambulatory Surgical Centers
      Other End Users

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central and South America

      The study objectives of this report are:
      To analyze global Embolotherapy status, future forecast, growth opportunity, key market and key players.
      To present the Embolotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Embolotherapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now